HOME >> BIOLOGY >> NEWS
Compound from rare plant shows promise in treating breast cancer

CHARLOTTESVILLE, Va., Feb. 1, 2005 -- They started with a bare room and an idea. Now, after five years of painstaking, sophisticated tests, scientists at the University of Virginia Health System have discovered that a compound, derived from a rare South American plant, stops the growth of human breast cancer cells in laboratory cultures.

U. Va. Health System scientists Deborah Lannigan and Jeffrey Smith hope that, after further testing, their discovery could translate into a successful drug for the treatment of breast cancer. The disease is the second leading cancer killer of women in the U.S., according to the American Cancer Society, with an estimated 40,410 deaths.

The compound, called SL0101, comes from the plant Forsteronia refracta, a nondescript member of the dogbane family found in the Amazonian rain forest. The compound works like a key in a molecular lock. It inhibits the action of a cancer-linked protein called RSK, which the researchers discovered is important for controlling the growth of breast cancer cells. Interestingly, SL0101 does not alter the growth of normal breast cells. The discovery is detailed in the Feb. 1, 2005 issue of the journal Cancer Research and can be found online at: www.cancerres.aacrjournals.org.

"By preventing RSK from working, we completely stopped the growth of breast cancer cells but did not affect the growth of normal breast cells," said Lannigan, an Assistant Professor of Microbiology at the U. Va. Cancer Center. She compares this discovery to the development of the drug Gleevec for the treatment of chronic myeloid leukemia. Like Gleevec, SL0101 is a signal transduction inhibitor that interferes with the pathways that signal the growth of tumors. "Gleevec is an exciting discovery and we're hoping to have similar success with SL0101," Lannigan said.

For now, Lannigan and Smith have begun testing the compound in anima
'"/>

Contact: Bob Beard
reb8e@virginia.edu
434-982-4490
University of Virginia Health System
1-Feb-2005


Page: 1 2

Related biology news :

1. Scripps research scientists: Compounds show significant promise against potential bioweapon toxins
2. Compound eyes, evolutionary ties
3. Compounds in cranberry juice show promise as alternatives to antibiotics
4. Compound in wine reduces levels of Alzheimers disease-causing peptides
5. Compound reveals new link between signaling protein and cell migration
6. Compound from Chinese medicine shows promise in head and neck cancer
7. Animal study: Compounds in cranberries may have heart-healthy effects
8. Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds
9. Compounds in plastic packaging act as environmental estrogens altering breast genes
10. Compound inhibits one critical pathway in breast cancer growth
11. Circadian clock controls plant growth hormone

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... 02, 2018 , ... Stem Cell Innovations (SCI), a global network of professionals ... therapy, has launched the pre-sale for their ICO with participants purchasing SCIA ... connect patients and stem cell specialists around the world. , SCI (formally ...
(Date:10/1/2018)... ... October 01, 2018 , ... NanoValent ... (ADC) like, lipid based therapeutics, today announced the National Institute of Health ... award of first year funding for two separate grants. These two grants will ...
(Date:10/1/2018)... Calif. (PRWEB) , ... October ... ... of post-translational modifications (PTMs) presents a unique challenge to proteomic studies. Often, ... within each protein. Although label-free data-independent acquisitions (DIA, or SWATH®Acquisition) have been ...
Breaking Biology News(10 mins):
(Date:10/13/2018)... , ... October 12, 2018 , ... ... society for laser education, innovation and commercialization, celebrates its 50th birthday in New ... Applications of Lasers and Electro-Optics (ICALEO) conference. , In celebration of its ...
(Date:10/5/2018)... ... October 04, 2018 , ... ... along with Duke University, announced today at IDWeek™ 2018 the positive results of ... pathogen DNA in plasma, accurately identified causative pathogens in patients with infective endocarditis ...
(Date:10/2/2018)... ... October 02, 2018 , ... Finalists for the 2018 ... AssurEOR product line was chosen for its advancements in the production chemicals category. ... innovations in upstream oil applications that are positively impacting the industry. The winners ...
(Date:9/28/2018)... ... September 28, 2018 , ... LabRoots , the ... scientists from around the world, is excited to announce Daniel Andrade, a 22-year-old ... the winner of the LabRoots Summer 2018 Textbook Scholarship, awarding him $1,000 to ...
Breaking Biology Technology:
Cached News: